Clinical Evaluation of Florbetapir F 18 (18F-AV-45)

Completed · Phase 2

Conditions studied: Alzheimer Disease, Mild Cognitive Impairment, Neurodegenerative Diseases

In brief

This protocol is designed to standardize imaging studies using florbetapir F 18 PET to provide information on amyloid burden in subjects participating in other studies (companion protocol) such as longitudinal studies of aging and studies of biomarkers for neurodegenerative diseases.

Key facts

Study ID
NCT01518374
Run by
Avid Radiopharmaceuticals
People needed
1768
Starts
2009-12-01
Expected to finish
2017-05-03
Last updated by the study team
2018-07-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.